PharmaTech

JUNE 10, 2025

s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. Kennedy Jr.

Vaccines 85

Vaccines Insurance Coverage and Processing Dosage Drug Development 85

Pharmaceutical Technology

JULY 14, 2025

How will RFK Jr’s American dream for vaccines play out? Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma Formulate Faster. MAXSHOT.PL via Shutterstock. A decision by the FDA is expected in H1 2026.

Labelling 52

Labelling Vaccines Insurance Coverage and Processing Packaging 52

Pharmaceutical Technology

JUNE 20, 2025

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content. Give your business an edge with our leading industry insights.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Hospitals Communication Pharmaceutical Manufacturing 52

Pharmaceutical Technology

JULY 14, 2025

How will RFK Jr’s American dream for vaccines play out? Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma Formulate Faster. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Communication Packaging Hospitals 52

Pharmaceutical Technology

JULY 9, 2025

How will RFK Jr’s American dream for vaccines play out? JCR has also developed a proprietary blood-brain barrier-penetrating technology, J-Brain Cargo, to deliver biotherapeutics into the central nervous system. IZCARGO is the first drug developed with this technology and approved in Japan for treating a lysosomal storage disorder.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Packaging Communication Hospitals 52

Pharmaceutical Technology

JUNE 27, 2025

Find out more Under the MoU, both companies will focus on advancing the development and mass production of lentiviral vectors, which are essential for CAR T-cell therapies used in treating leukaemia and other cancers. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Communication Packaging Hospitals 52

Pharmaceutical Technology

JUNE 20, 2025

Unlike vaccines, the agency leaders see the modality as a path to prevent and cure disease – aligning with the current administration’s wider national health strategy. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Topic sponsors are not involved in the creation of editorial content.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Communication Pharmaceutical Manufacturing Packaging 52